INMD Stock Analysis: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$15.71
-0.31 (-1.94%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called INMD this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INMD shows positive signals but monitor for confirmation. Market pricing in 4.0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: INMD shows positive signals but monitor for confirmation. Market pricing in 4.0% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.21
Based on 3.9% avg growth
INTRINSIC VALUE TODAY
$10.69
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $15.71, which is considered extended relative to its 30-day fair value range of $14.06 to $15.29. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.8) compared to its historical average (8.7). At these levels, the market is pricing in 4.0% annual earnings growth.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $16.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $16.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$14.06 -
$15.29
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($16.60)
- BULLISH: Expecting earnings turnaround to 4.0% growth with -28.5% revenue growth
Fair Price Analysis
30-Day Fair Range
$14.06 -
$15.29
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$13.73
Resistance Level
$16.12
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
9.81
Wall Street Target
$16.60
(+3.6%)
Revenue Growth (YoY)
-28.5%
Earnings Growth (YoY)
-47.7%
Profit Margin
41.0%
Valuation Premium vs History
+4.0% premium
PE vs Historical
9.8 vs 8.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.0%
(market-implied from PE analysis)
1-Year Target
$16.66
(+4%)
2-Year Target
$17.33
(+8%)
3-Year Target
$18.02
(+13%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$15.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 3.8%)
$40.74
(+154%)
Base:
(SPY PE: 9.8, Growth: 3.8%)
$17.92
(+12%)
Bear:
(PE: 8.3, Growth: 3.8%)
$15.23
(-5%)
📈
Valuation based on Current Earnings
Trailing PE: 7.27 | Current EPS (TTM): $2.08
Bull Case
$13.06
(-17%)
Analyst growth -21.5%, PE expands to 8.0
Base Case
$11.88
(-24%)
Market implied -21.5%, PE stable at 7.3
Bear Case
$10.28
(-35%)
Severe decline -20.0%, PE contracts to 6.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 2:49 PM ET
Data refreshes hourly during market hours. Next update: 3:49 PM
Data refreshes hourly during market hours. Next update: 3:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced INMD Option Strategies
Professional options setups generated by AI based on today's INMD price and gamma walls.
